Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort.
Belgium
COVID-19
clinical characteristics
outcomes
people living with HIV
Journal
Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
revised:
11
01
2021
received:
17
09
2020
accepted:
22
01
2021
pubmed:
29
1
2021
medline:
22
4
2021
entrez:
28
1
2021
Statut:
ppublish
Résumé
The aim of this study was to describe the clinical characteristics and outcomes of coronavirus disease 2019 (COVID-19) among people living with HIV (PLWH) in Belgium. We performed a retrospective multicenter cohort analysis of PLWH with either laboratory-confirmed, radiologically diagnosed, or clinically suspected COVID-19 between February 15, 2020 and May 31, 2020. The primary endpoint was outcome of COVID-19. Secondary endpoints included rate of hospitalization and length of hospital stay and rate of Intensive Care Unit (ICU) admission and mechanical ventilation. One hundred and one patients were included in this study. Patients were categorized as having either laboratory-confirmed (n = 65), radiologically-diagnosed (n = 3), or clinically suspected COVID-19 (n = 33). The median age was 51.3 years (interquartile range [IQR] 41.3-57.3) and 44% were female. Ninety-four percent of patients were virologically suppressed and 67% had a CD4
Identifiants
pubmed: 33506953
doi: 10.1002/jmv.26828
pmc: PMC8014531
doi:
Types de publication
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
2971-2978Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Lancet. 2003 May 24;361(9371):1767-72
pubmed: 12781535
Clin Infect Dis. 2020 Nov 19;71(16):2294-2297
pubmed: 32472138
Lancet HIV. 2020 May;7(5):e314-e316
pubmed: 32304642
Infection. 2020 Oct;48(5):681-686
pubmed: 32394344
J Med Virol. 2021 May;93(5):2971-2978
pubmed: 33506953
Life Sci. 2020 Jul 15;253:117592
pubmed: 32222463
J Infect Dis. 2021 Feb 13;223(3):403-408
pubmed: 32601704
Clin Infect Dis. 2020 Nov 5;71(8):2021-2022
pubmed: 32459833
Ann Intern Med. 2020 Oct 6;173(7):536-541
pubmed: 32589451
J Med Virol. 2020 Nov;92(11):2387-2389
pubmed: 32462663
J Med Virol. 2020 Oct;92(10):1777-1778
pubmed: 32293709
Antiviral Res. 2020 Jun;178:104786
pubmed: 32251767
J Int AIDS Soc. 2020 Jul;23(7):e25568
pubmed: 32697865
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Lancet HIV. 2020 Aug;7(8):e554-e564
pubmed: 32473657
AIDS. 2020 Jul 1;34(8):1255-1256
pubmed: 32501850
Emerg Infect Dis. 2013 Nov;19(11):1766-74
pubmed: 24209781
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Ann Intern Med. 2014 Mar 18;160(6):389-97
pubmed: 24474051